As of 12:31 PM on the 14th, Seegene is trading at 250,300 KRW, up 0.32% from the previous day. This represents a 13.05% increase compared to August 14. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

Today, foreigners are tentatively recorded as net sellers of 10,000 shares. Over the past five days, individual investors have net sold 103,114 shares, while foreigners and institutions have net sold 110,435 shares and net bought 215,306 shares, respectively.


On September 8, Seegene was a market topic with the headline "Strong performance on the global launch of new COVID-19 and flu differential diagnostic products."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing